TABLE 1

Physicochemical and PK parameters of atomoxetine used in the PBPK model development

ParameterValueReference
Physicochemical
 Molecular Weight (g/mol)255.36Stattera NDA
 Log P3.9NDA
 pKa9.8NDA
fu0.025NDA
 B/P0.623Simcyp prediction toolbox
Absorption
Fa0.96
ka (l/h)1.2Optimized
 Qgut (l/h)11.9Simcyp prediction toolbox
Distribution
 Vss (l/kg)0.74Simcyp prediction 
full PBPK method 2
Metabolism/elimination
 CLi.v. (l/h)16.3NDA
 CLr (l/h)0.185Sauer et al. (2003)
fm,CYP2D60.876
Recombinant CLint (μl/min/pmol)
 CYP2D625.4
 CYP2C191.84
P450 enzyme abundance (pmol/mg microsomal protein)
 CYP2D6 EM8 (61)aSimcyp default value
 CYP2C19 EM14 (40)aOptimized
Interaction
 CYP2D6 Ki (μM)34.3Sauer et al. (2004)
 CYP3A4 Ki (μM)3.6Sauer et al. (2004)
  • B/P, blood-to-plasma ratio; CLi.v., clearance after intravenous administration; CLr, renal clearance; Fa, fraction absorbed; fm, fraction metabolized; fu, fraction unbound in plasma; ka, absorption rate constant; Ki, inhibition constant; Log P, log octanol:water partition coefficient; Qgut, drug absorption flow to intestine; Vss, volume of distribution at steady state.

  • a Mean value (coefficient of variance).